The Emotion Builder: An Intervention for Emotional Deficits After Brain Injury

Sponsor
EmotEd (Industry)
Overall Status
Completed
CT.gov ID
NCT02432300
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
17
1
1
13
1.3

Study Details

Study Description

Brief Summary

The purpose of this study is to examine a web-based training program for treating emotional problems in people who have suffered a traumatic brain injury (TBI).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Emotion Builder
N/A

Detailed Description

This is a pilot study to examine how subjects with TBI feel about the virtual reality program as a treatment and to assess the effectiveness of the virtual reality program at increasing subjects' awareness and understanding of emotions.

Study Design

Study Type:
Interventional
Actual Enrollment :
17 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Emotion Builder: An Intervention for Emotional Deficits After Brain Injury
Study Start Date :
May 1, 2015
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
Jun 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Treatment sessions with a virtual treatment program called Emotion Builder

Behavioral: Emotion Builder
Total of 8 therapy sessions with the Emotion Builder over approximately four (4) weeks (2 sessions a week)

Outcome Measures

Primary Outcome Measures

  1. Toronto Alexithymia Scale-20 (TAS-20) [Week 6]

    This is a 20-item self-report questionnaire comprised of three sub-constructs (Difficulty Identifying feelings, Difficulty Describing Feelings, Externally-oriented Thinking). The full scale range is 20-100 (higher scores indicate higher alexithymia). Subscales are summed to compute a total score Scores between 52 and 60 indicate moderate alexithymia; scores 61 and higher indicate high alexithymia.

  2. Levels of Emotional Awareness Scale (LEAS) [Week 6]

    The LEAS is comprised of ten hypothetical scenarios that are three or four sentences in length. Participants must respond how they think they would feel and how another person would feel in response to the hypothetical scenario. The more discrete emotions (e.g., bad vs sad) receive higher points, as well as blended emotions (e.g. sad and angry). There are 10 items on this measure. The minimum score for each item is 0 and the max score for each item is 5. The item scores are summed to calculate a total score. Thus, the total scores range from 0-50; 0=lowest awareness and 50=highest awareness. A computerized scoring system and parallel forms were used.

Secondary Outcome Measures

  1. Patient Health Questionnaire-9 (PHQ-9) as an Assessment of Depression [Week 6]

    The PHQ-9 is a self-report questionnaire designed to assess depression through nine questions that come directly from the DSM-IV signs and symptoms of major depression. The 9 items describe problems associated with depression, and participants must rate how often they have been bothered by the problems in the last 2 weeks on a 0-3 scale. The scores are summed for a total depression score, ranging from 0-27, which higher scores indicating greater depression.

  2. State Trait Anxiety Inventory (STAI) [Week 6]

    The STAI is a self-report measure of state and trait anxiety (20 items each). The trait anxiety subscale was the variable of interest for this study. Higher scores indicate more trait or state anxiety. Scores for each scale range from 20-80, with higher scores indicating greater anxiety. The raw scores were converted into T scores using age and gender norms provided by the authors for the STAI. A score of 50 represents the mean. A difference of 10 from the mean indicates a difference of one standard deviation. Higher T scores were still indicative of higher anxiety. We reported T scores for trait anxiety.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • TBI (injury due to an external physical force);

  • Moderate to severe TBI, defined either by74 Glasgow Coma Score at time of injury (≤12), or post-traumatic amnesia (≥1 day), or loss of consciousness (≥30 minutes);

  • ≥1 year post-injury;

  • between 18-65 years old;

  • Have a moderate to high alexithymia score (≥52) on the TAS-2070 at screening.

Exclusion criteria:
  • Diagnosed with pre-morbid neurological disorders (e.g. stroke, autism, alzheimer's disease, Parkinson's disease);

  • Formerly diagnosed with a developmental disability;

  • Pre-morbid diagnosis of major psychiatric disorders (e.g. schizophrenia);

  • Unable to follow directions;

  • Uncorrected visual or hearing impairments that would prevent sufficient task participation;

  • No access to reliable transportation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Indiana University Health Facilities Indianapolis Indiana United States 46202

Sponsors and Collaborators

  • EmotEd
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

  • Principal Investigator: Dawn Neumann, PhD, Indiana University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dawn Neumann, Assistant Research Professor, Department of Physical Medicine and Rehabilitation, IU School of Medicine, Indiana University
ClinicalTrials.gov Identifier:
NCT02432300
Other Study ID Numbers:
  • 1R41HD077967-01A1
  • 1404681990
  • 1R41HD077967-01A1
First Posted:
May 4, 2015
Last Update Posted:
Nov 22, 2017
Last Verified:
Nov 1, 2017
Keywords provided by Dawn Neumann, Assistant Research Professor, Department of Physical Medicine and Rehabilitation, IU School of Medicine, Indiana University
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail Participants were only enrolled in the treatment if they were found to have met the criteria for moderate to severe alexithymia on the Toronto Alexithymia Scale 20 (>=52).
Arm/Group Title Treatment Group (Emotion Builder)
Arm/Group Description The intervention was a web-based treatment program called the Emotion Builder that was delivered by a clinician research assistant individually to participants. Emotion Builder: Total of 8 therapy sessions (60-90 minutes each) over approximately four (4) weeks (2 sessions a week). The objective of these sessions were to increase emotional awareness and labeling. Lessons included exercises designed to build emotional vocabulary, lessons to help differentiate emotions, activities to enhance attention to changes in body states associated with emotional responses (emotional arousal), and virtual videos simulating emotional scenarios for practicing lessons learned.
Period Title: Overall Study
STARTED 17
COMPLETED 13
NOT COMPLETED 4

Baseline Characteristics

Arm/Group Title Treatment Group (Emotion Builder)
Arm/Group Description The intervention was a web-based treatment program called the Emotion Builder that was delivered by a clinician research assistant individually to participants. Emotion Builder: Total of 8 therapy sessions (60-90 minutes each) over approximately four (4) weeks (2 sessions a week). The objective of these sessions were to increase emotional awareness and labeling. Lessons included exercises designed to build emotional vocabulary, lessons to help differentiate emotions, activities to enhance attention to changes in body states associated with emotional responses (emotional arousal), and virtual videos simulating emotional scenarios for practicing lessons learned.
Overall Participants 17
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
46.12
(11.41)
Sex: Female, Male (Count of Participants)
Female
4
23.5%
Male
13
76.5%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
Asian
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
Black or African American
0
0%
White
17
100%
More than one race
0
0%
Unknown or Not Reported
0
0%
Toronto Alexithymia Scale (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
61.54
(7.26)
Levels of Emotional Awareness Scale (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
36.92
(7.88)
PHQ 9 (Depression) (units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [units on a scale]
10.77
(4.82)
Trait Anxiety (State Trait Anxiety Inventory) (T score) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [T score]
68.38
(11.45)

Outcome Measures

1. Primary Outcome
Title Toronto Alexithymia Scale-20 (TAS-20)
Description This is a 20-item self-report questionnaire comprised of three sub-constructs (Difficulty Identifying feelings, Difficulty Describing Feelings, Externally-oriented Thinking). The full scale range is 20-100 (higher scores indicate higher alexithymia). Subscales are summed to compute a total score Scores between 52 and 60 indicate moderate alexithymia; scores 61 and higher indicate high alexithymia.
Time Frame Week 6

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment Group (Emotion Builder)
Arm/Group Description The intervention was a web-based treatment program called the Emotion Builder that was delivered by a clinician research assistant individually to participants. Emotion Builder: Total of 8 therapy sessions (60-90 minutes each) over approximately four (4) weeks (2 sessions a week). The objective of these sessions were to increase emotional awareness and labeling. Lessons included exercises designed to build emotional vocabulary, lessons to help differentiate emotions, activities to enhance attention to changes in body states associated with emotional responses (emotional arousal), and virtual videos simulating emotional scenarios for practicing lessons learned.
Measure Participants 13
Mean (Standard Deviation) [units on a scale]
52.54
(11.95)
2. Primary Outcome
Title Levels of Emotional Awareness Scale (LEAS)
Description The LEAS is comprised of ten hypothetical scenarios that are three or four sentences in length. Participants must respond how they think they would feel and how another person would feel in response to the hypothetical scenario. The more discrete emotions (e.g., bad vs sad) receive higher points, as well as blended emotions (e.g. sad and angry). There are 10 items on this measure. The minimum score for each item is 0 and the max score for each item is 5. The item scores are summed to calculate a total score. Thus, the total scores range from 0-50; 0=lowest awareness and 50=highest awareness. A computerized scoring system and parallel forms were used.
Time Frame Week 6

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment Group (Emotion Builder)
Arm/Group Description The intervention was a web-based treatment program called the Emotion Builder that was delivered by a clinician research assistant individually to participants. Emotion Builder: Total of 8 therapy sessions (60-90 minutes each) over approximately four (4) weeks (2 sessions a week). The objective of these sessions were to increase emotional awareness and labeling. Lessons included exercises designed to build emotional vocabulary, lessons to help differentiate emotions, activities to enhance attention to changes in body states associated with emotional responses (emotional arousal), and virtual videos simulating emotional scenarios for practicing lessons learned.
Measure Participants 13
Mean (Standard Deviation) [units on a scale]
44.23
(5.23)
3. Secondary Outcome
Title Patient Health Questionnaire-9 (PHQ-9) as an Assessment of Depression
Description The PHQ-9 is a self-report questionnaire designed to assess depression through nine questions that come directly from the DSM-IV signs and symptoms of major depression. The 9 items describe problems associated with depression, and participants must rate how often they have been bothered by the problems in the last 2 weeks on a 0-3 scale. The scores are summed for a total depression score, ranging from 0-27, which higher scores indicating greater depression.
Time Frame Week 6

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment Group (Emotion Builder)
Arm/Group Description The intervention was a web-based treatment program called the Emotion Builder that was delivered by a clinician research assistant individually to participants. Emotion Builder: Total of 8 therapy sessions (60-90 minutes each) over approximately four (4) weeks (2 sessions a week). The objective of these sessions were to increase emotional awareness and labeling. Lessons included exercises designed to build emotional vocabulary, lessons to help differentiate emotions, activities to enhance attention to changes in body states associated with emotional responses (emotional arousal), and virtual videos simulating emotional scenarios for practicing lessons learned.
Measure Participants 13
Mean (Standard Deviation) [units on a scale]
9.69
(5.25)
4. Secondary Outcome
Title State Trait Anxiety Inventory (STAI)
Description The STAI is a self-report measure of state and trait anxiety (20 items each). The trait anxiety subscale was the variable of interest for this study. Higher scores indicate more trait or state anxiety. Scores for each scale range from 20-80, with higher scores indicating greater anxiety. The raw scores were converted into T scores using age and gender norms provided by the authors for the STAI. A score of 50 represents the mean. A difference of 10 from the mean indicates a difference of one standard deviation. Higher T scores were still indicative of higher anxiety. We reported T scores for trait anxiety.
Time Frame Week 6

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment Group (Emotion Builder)
Arm/Group Description The intervention was a web-based treatment program called the Emotion Builder that was delivered by a clinician research assistant individually to participants. Emotion Builder: Total of 8 therapy sessions (60-90 minutes each) over approximately four (4) weeks (2 sessions a week). The objective of these sessions were to increase emotional awareness and labeling. Lessons included exercises designed to build emotional vocabulary, lessons to help differentiate emotions, activities to enhance attention to changes in body states associated with emotional responses (emotional arousal), and virtual videos simulating emotional scenarios for practicing lessons learned.
Measure Participants 13
Mean (Standard Deviation) [units on a scale]
61.54
(12.08)

Adverse Events

Time Frame One year. From the start of participant enrollment until the last day of testing.
Adverse Event Reporting Description
Arm/Group Title Treatment Group (Emotion Builder)
Arm/Group Description 8 sessions of a web-based treatment, each lasting 60-90 minutes, twice per week over 4 weeks with a clinician research assistant. This treatment aimed to improve emotional awareness and labeling.
All Cause Mortality
Treatment Group (Emotion Builder)
Affected / at Risk (%) # Events
Total / (NaN)
Serious Adverse Events
Treatment Group (Emotion Builder)
Affected / at Risk (%) # Events
Total 0/17 (0%)
Other (Not Including Serious) Adverse Events
Treatment Group (Emotion Builder)
Affected / at Risk (%) # Events
Total 1/17 (5.9%)
Psychiatric disorders
Emotional Distress 1/17 (5.9%) 1

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dawn Neumann
Organization EmotEd, LLC
Phone 716-713-5048
Email dneumann73@gmail.com
Responsible Party:
Dawn Neumann, Assistant Research Professor, Department of Physical Medicine and Rehabilitation, IU School of Medicine, Indiana University
ClinicalTrials.gov Identifier:
NCT02432300
Other Study ID Numbers:
  • 1R41HD077967-01A1
  • 1404681990
  • 1R41HD077967-01A1
First Posted:
May 4, 2015
Last Update Posted:
Nov 22, 2017
Last Verified:
Nov 1, 2017